Additional Gadoxetic Acid Enhanced-MRI for Liver Metastases

Trial Profile

Additional Gadoxetic Acid Enhanced-MRI for Liver Metastases

Phase of Trial: Phase IV

Latest Information Update: 09 Mar 2018

At a glance

  • Drugs Gadoxetate disodium (Primary)
  • Indications Liver cancer
  • Focus Diagnostic use
  • Most Recent Events

    • 09 Mar 2018 Status changed from active, no longer recruiting to completed.
    • 02 Sep 2015 Status changed from not yet recruiting to active, no longer recruiting, as reported by University Hospital Medical Information Network - Japan record.
    • 03 Sep 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top